PPG
40
3
KMX
70
5
CMCSA
46
5
SCHW
62
4
VIX
25
-18
ETN
76
3
MOS
49
-6
ORLY
47
-3
R
73
2
PCG
56
5
AXP
69
2
L
43
-2
MCO
71
4
BWA
41
3
KMI
57
2
STI
35
3
EXPE
51
3
NWS
76
2
BLK
58
3
JBHT
28
2
PPG
40
3
KMX
70
5
CMCSA
46
5
SCHW
62
4
VIX
25
-18
ETN
76
3
MOS
49
-6
ORLY
47
-3
R
73
2
PCG
56
5
AXP
69
2
L
43
-2
MCO
71
4
BWA
41
3
KMI
57
2
STI
35
3
EXPE
51
3
NWS
76
2
BLK
58
3
JBHT
28
2
Financhill
Back

Kuros Biosciences 10K Form

Sell
47

CSBTF
Kuros Biosciences

Last Price:
$33.22
Seasonality Move:
9.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CSBTF News And Ratings

See the #1 stock for the next 7 days that we like better than CSBTF

CSBTF Financial Statistics

Sales & Book Value

Annual Sales: $85.8M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $1.72
Price / Book: 19.39

Profitability

EPS (TTM): -0.11640
Net Income (TTM): $-4.2M
Gross Margin: $70.5M
Return on Equity: -6.35%
Return on Assets: -4.79%

Kuros Biosciences Earnings Forecast

Key Kuros Biosciences Financial Ratios

  • The Gross Profit Margin over the past 19 years for CSBTF is 82.10%.
  • The Selling, General & Administrative Expenses for CSBTF have been equal to 54.61% of Gross Profit Margin.
  • The Research & Development expenses have been 9.24% of Revenue.
  • The Net Earning history of CSBTF is -4.92% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Kuros Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CSBTF
Website: kurosbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.14
Quick Ratio: 1.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CSBTF Technical Analysis vs Fundamental Analysis

Sell
47
Kuros Biosciences (CSBTF) is a Sell

Is Kuros Biosciences a Buy or a Sell?